Author

Cong Zhang

Institution: Suzhou Zelgen Biopharmaceuticals Co., Ltd. (China)

Observed institutions: Yangtze University, Fourth Hospital of Hebei Medical University, Suzhou Zelgen Biopharmaceuticals Co., Ltd. (China)

ORCID: 0000-0003-2736-988X

Observed ORCID: 0000-0003-2736-988X

OpenAlex ID: A5007333215

The NR_109/FUBP1/c-Myc axis regulates TAM polarization and remodels the tumor microenvironment to promote cancer development

2023 · Cong Zhang, Sisi Wei, et al. · Journal for ImmunoTherapy of Cancer · 84

P-Hydroxylcinnamaldehyde induces tumor-associated macrophage polarization toward the M1 type by regulating the proteome and inhibits ESCC in vivo and in vitro

2023 · Xiaohan Wang, Sisi Wei, et al. · International Immunopharmacology · 12

LncRNA SNHG5 Suppresses Cell Migration and Invasion of Human Lung Adenocarcinoma via Regulation of Epithelial-Mesenchymal Transition

2023 · Zhirong Li, Yipeng Wu, et al. · Journal of Oncology · 8

Changing trends in disease burden of lung cancer in China from 1990-2019 and following 15-year prediction

2023 · Di Zhao, Jinzhi Lu, et al. · Current Problems in Cancer · 3

Absorption, metabolism, and excretion of oral [14C] radiolabeled donafenib: an open-label, phase I, single-dose study in humans

2024 · Sheng Ma, Ling Yi, et al. · Cancer Chemotherapy and Pharmacology · 2

Works count: 5

Citation count: 109

H-index: 3

I10-index: 2